These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21825224

  • 1. Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor.
    Matsuura H, Ichiki T, Ikeda J, Takeda K, Miyazaki R, Hashimoto T, Narabayashi E, Kitamoto S, Tokunou T, Sunagawa K.
    Hypertension; 2011 Sep; 58(3):386-93. PubMed ID: 21825224
    [Abstract] [Full Text] [Related]

  • 2. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
    Schultz K, Murthy V, Tatro JB, Beasley D.
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
    [Abstract] [Full Text] [Related]

  • 3. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
    Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, Sunagawa K.
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1263-9. PubMed ID: 18420994
    [Abstract] [Full Text] [Related]

  • 4. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury.
    Barnucz E, Veres G, Hegedűs P, Klein S, Zöller R, Radovits T, Korkmaz S, Horkay F, Merkely B, Karck M, Szabó G.
    J Pharmacol Exp Ther; 2013 Apr; 345(1):25-31. PubMed ID: 23388095
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.
    Takeda K, Ichiki T, Narabayashi E, Inanaga K, Miyazaki R, Hashimoto T, Matsuura H, Ikeda J, Miyata T, Sunagawa K.
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2132-7. PubMed ID: 19762779
    [Abstract] [Full Text] [Related]

  • 6. Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS.
    Yu J, Wang S, Shi W, Zhou W, Niu Y, Huang S, Zhang Y, Zhang A, Jia Z.
    JCI Insight; 2021 Sep 22; 6(18):. PubMed ID: 34403364
    [Abstract] [Full Text] [Related]

  • 7. Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94.
    Baek JH, Reiter CE, Manalo DJ, Buehler PW, Hider RC, Alayash AI.
    Biochim Biophys Acta; 2011 Sep 22; 1809(4-6):262-8. PubMed ID: 21558026
    [Abstract] [Full Text] [Related]

  • 8. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS, Kiriakidis S, Paleolog EM, Davies AH.
    J Vasc Surg; 2012 May 22; 55(5):1427-39. PubMed ID: 22277691
    [Abstract] [Full Text] [Related]

  • 9. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I, Ichiki T, Inanaga K, Ohtsubo H, Fukuyama K, Ono H, Hashiguchi Y, Sunagawa K.
    Cardiovasc Res; 2006 Oct 01; 72(1):184-90. PubMed ID: 16938288
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells.
    Wang Z, Tang L, Zhu Q, Yi F, Zhang F, Li PL, Li N.
    Kidney Int; 2011 Feb 01; 79(3):300-10. PubMed ID: 20881940
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of prolyl hydroxylase domain-containing protein: a novel therapy for cardiovascular diseases?
    Takayanagi T, Eguchi S.
    Hypertension; 2011 Sep 01; 58(3):354-5. PubMed ID: 21825225
    [No Abstract] [Full Text] [Related]

  • 12. Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells.
    Cioffi CL, Liu XQ, Kosinski PA, Garay M, Bowen BR.
    Biochem Biophys Res Commun; 2003 Apr 11; 303(3):947-53. PubMed ID: 12670503
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of hypoxia-inducible factor prolyl hydoxylase-2 attenuates hypoxia-induced vascular endothelial growth factor expression in luteal cells.
    Zhang Z, Pang X, Tang Z, Yin D, Wang Z.
    Mol Med Rep; 2015 Sep 11; 12(3):3809-3814. PubMed ID: 25975603
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia-inducible factor 1alpha modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells.
    Corley KM, Taylor CJ, Lilly B.
    J Cell Biochem; 2005 Dec 01; 96(5):971-85. PubMed ID: 16149050
    [Abstract] [Full Text] [Related]

  • 15. Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts.
    Vengellur A, Woods BG, Ryan HE, Johnson RS, LaPres JJ.
    Gene Expr; 2003 Dec 01; 11(3-4):181-97. PubMed ID: 14686790
    [Abstract] [Full Text] [Related]

  • 16. Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension.
    Le Gal L, Pellegrin M, Santoro T, Mazzolai L, Kurtz A, Meda P, Wagner C, Haefliger JA.
    J Am Heart Assoc; 2019 Apr 16; 8(8):e010823. PubMed ID: 30943815
    [Abstract] [Full Text] [Related]

  • 17. Vascular induction of a disintegrin and metalloprotease 17 by angiotensin II through hypoxia inducible factor 1α.
    Obama T, Takayanagi T, Kobayashi T, Bourne AM, Elliott KJ, Charbonneau M, Dubois CM, Eguchi S.
    Am J Hypertens; 2015 Jan 16; 28(1):10-4. PubMed ID: 24871629
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
    Wang W, Xu B, Xuan H, Ge Y, Wang Y, Wang L, Huang J, Fu W, Michie SA, Dalman RL.
    J Vasc Surg; 2018 Nov 16; 68(5):1538-1550.e2. PubMed ID: 29242064
    [Abstract] [Full Text] [Related]

  • 19. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ, Tian YM, Mole DR, Harris AL.
    Circ Res; 2004 Jul 23; 95(2):162-9. PubMed ID: 15192023
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
    Castejon AM, Zollner E, Tristano AG, Cubeddu LX.
    J Cardiovasc Pharmacol; 2007 Dec 23; 50(6):708-11. PubMed ID: 18091590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.